Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell function.
- DOI
- 10.1073/pnas.2603440123
- Published
- 2026 Jun 23
- Container
- Proceedings of the National Academy of Sciences of the United States of America
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1073/pnas.2603440123,
title = {Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell function.},
author = {Kieliszek AM and Apel E and Zheng S and Piotrowski M and Chui D and Alazet S and Shamsi S and Mobilio D and Johnson JW and Escudero L and Vandevoorde K and Mei L and Acevedo M and Sabbatani J and Kent OA and Dordahan F and Yadav A and MacKay B and Leguay K and Berger KJ and Miletic P and Zhai K and Ang P and Huebner A and Chafe SC and Sturino C and Szychowski J and Venugopal C and Mancini J and Phinney AL and Magolan J and Singh SK},
year = {2026},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
doi = {10.1073/pnas.2603440123},
url = {https://doi.org/10.1073/pnas.2603440123}
}RIS
TY - JOUR TI - Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell function. AU - Kieliszek AM AU - Apel E AU - Zheng S AU - Piotrowski M AU - Chui D AU - Alazet S AU - Shamsi S AU - Mobilio D AU - Johnson JW AU - Escudero L AU - Vandevoorde K AU - Mei L AU - Acevedo M AU - Sabbatani J AU - Kent OA AU - Dordahan F AU - Yadav A AU - MacKay B AU - Leguay K AU - Berger KJ AU - Miletic P AU - Zhai K AU - Ang P AU - Huebner A AU - Chafe SC AU - Sturino C AU - Szychowski J AU - Venugopal C AU - Mancini J AU - Phinney AL AU - Magolan J AU - Singh SK PY - 2026 JO - Proceedings of the National Academy of Sciences of the United States of America DO - 10.1073/pnas.2603440123 UR - https://doi.org/10.1073/pnas.2603440123 ER -
APA
AM, K., E, A., S, Z., M, P., D, C., S, A., S, S., D, M., JW, J., L, E., K, V., L, M., M, A., J, S., OA, K., F, D., A, Y., B, M., K, L., KJ, B., P, M., K, Z., P, A., A, H., SC, C., C, S., J, S., C, V., J, M., AL, P., J, M., & SK, S. (2026). Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell function.. Proceedings of the National Academy of Sciences of the United States of America. https://doi.org/10.1073/pnas.2603440123
Source records
- pubmed · retrieved 2026-09-26T14:10:03.014Z